expansion cohort

October 31, 2019

Cirmtuzumab-Imbruvica Combo Trial Opens New Expansion Part for Mantle Cell Lymphoma

News

A Phase 1/2 trial assessing Oncternal Therapeutics‘ cirmtuzumab plus Imbruvica (ibrutinib) for the treatment of B-cell cancers is opening a Phase 1b extension part to continue studying the combination in people ... Read more

May 22, 2017

Betalutin Trial for Non-Hodgkin’s Lymphoma Patients Opens New Expansion Cohort

News

The LYMRIT 37-01 Phase 1/2 trial assessing Betalutin in non-Hodgkin’s lymphoma patients will continue to evaluate Betalutin administered after pre-dosing with lilotomab in a Phase 2 expansion cohort of Arm 4. The ... Read more